Published in

American Society for Pharmacology and Experimental Therapeutics, Journal of Pharmacology and Experimental Therapeutics, p. jpet.119.261008, 2020

DOI: 10.1124/jpet.119.261008

Links

Tools

Export citation

Search in Google Scholar

CSTI-300; a novel 5-HT3 receptor partial agonist with potential to treat patients with irritable bowel syndrome or carcinoid syndrome

Distributing this paper is prohibited by the publisher
Distributing this paper is prohibited by the publisher

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Red circle
Postprint: archiving forbidden
Question mark in circle
Published version: policy unknown
Data provided by SHERPA/RoMEO